Her main research concerns Immunology, Cell biology, Immune system, Innate immune system and Inflammation. Her Immunology research incorporates elements of Autophagy, Cancer research and Skeletal muscle. Her Cell biology research is multidisciplinary, incorporating perspectives in Platelet activation, Platelet, T cell and HMGB1.
Her Immune system research incorporates themes from Stromal cell and Chemotaxis. Her Innate immune system study incorporates themes from Cell, PTX3, Complement system and Immunity. She has researched Inflammation in several fields, including Tumor necrosis factor alpha, Insomnia and Stem cell.
Her primary scientific interests are in Immunology, Internal medicine, Inflammation, Cell biology and Immune system. Immunology is closely attributed to Skeletal muscle in her study. Her study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology and Endocrinology.
Her Inflammation research includes themes of Tumor necrosis factor alpha and Pathogenesis, Pathology. Her Cell biology research is multidisciplinary, relying on both Cell, Macrophage, HMGB1 and Antigen. Her research investigates the link between HMGB1 and topics such as Platelet activation that cross with problems in Integrin.
Her scientific interests lie mostly in Internal medicine, Severe acute respiratory syndrome coronavirus 2, Pneumonia, Cohort and Intensive care unit. Her studies in Internal medicine integrate themes in fields like Gastroenterology and Diabetes mellitus. Her Pneumonia study also includes fields such as
Patrizia Rovere-Querini works mostly in the field of Cohort, limiting it down to topics relating to Multivariate analysis and, in certain cases, Gestational age, In utero and Neonatal intensive care unit, as a part of the same area of interest. Her Intensive care unit study integrates concerns from other disciplines, such as Hormone, Neuroradiology, Disease and Testosterone. Patrizia Rovere-Querini performs multidisciplinary study in the fields of Blocking and Immunology via her papers.
Patrizia Rovere-Querini mainly focuses on Internal medicine, Mechanical ventilation, Disease, Retrospective cohort study and Emergency department. Her studies examine the connections between Internal medicine and genetics, as well as such issues in Diabetes mellitus, with regards to Survival analysis. Her research integrates issues of Coronary artery disease, Acute respiratory distress, Lung and Pulmonary thrombosis in her study of Disease.
Her Retrospective cohort study study combines topics in areas such as Pregnancy, Antiphospholipid syndrome, Intensive care and Standard treatment. Her Intensive care research includes elements of Respiratory function and Anakinra. Her work in Cohort addresses issues such as Survival rate, which are connected to fields such as Cohort study, Antibody and Antigen.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)
Daniel J. Klionsky;Amal Kamal Abdel-Aziz;Sara Abdelfatah;Mahmoud Abdellatif.
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study.
Giulio Cavalli;Giacomo De Luca;Corrado Campochiaro;Emanuel Della-Torre.
The Lancet Rheumatology (2020)
Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors.
Mario Gennaro Mazza;Rebecca De Lorenzo;Caterina Conte;Sara Poletti.
Brain Behavior and Immunity (2020)
HMGB1 is an endogenous immune adjuvant released by necrotic cells
Patrizia Rovere-Querini;Annalisa Capobianco;Paola Scaffidi;Barbara Valentinis.
EMBO Reports (2004)
Consensus guidelines for the detection of immunogenic cell death
Oliver Kepp;Laura Senovilla;Ilio Vitale;Erika Vacchelli.
Release of High Mobility Group Box 1 by Dendritic Cells Controls T Cell Activation via the Receptor for Advanced Glycation End Products
Ingrid E. Dumitriu;Paramita Baruah;Barbara Valentinis;Reinhard E. Voll.
Journal of Immunology (2005)
Induction of inflammatory and immune responses by HMGB1–nucleosome complexes: implications for the pathogenesis of SLE
Vilma Urbonaviciute;Barbara G. Fürnrohr;Silke Meister;Luis Munoz.
Journal of Experimental Medicine (2008)
Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis
Fabio Ciceri;Luigi Beretta;Anna Mara Scandroglio;Sergio Colombo.
Critical Care and Resuscitation (2020)
HMGB1: guiding immunity from within
Ingrid E. Dumitriu;Paramita Baruah;Angelo A. Manfredi;Marco E. Bianchi.
Trends in Immunology (2005)
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study.
Corrado Campochiaro;Emanuel Della-Torre;Giulio Cavalli;Giacomo De Luca.
European Journal of Internal Medicine (2020)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: